Anti-CD3 x anti-HER2 bispecific antibody effectively redirects armed T cells to inhibit tumor development and growth in hormone-refractory prostate cancer-bearing severe combined immunodeficient beige mice.

Source:http://linkedlifedata.com/resource/pubmed/id/15479495

Download in:

View as

General Info

PMID
15479495